nafamostat has been researched along with Stomach Neoplasms in 3 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Stomach Neoplasms: Tumors or cancer of the STOMACH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bone metastases from gastric cancer (GC) are considered a relatively uncommon finding; however, they are related to poorer prognosis." | 2.52 | Targeting mast cells in gastric cancer with special reference to bone metastases. ( Ammendola, M; De Sarro, G; Gadaleta, CD; Leporini, C; Marech, I; Oakley, C; Ranieri, G; Russo, E; Sacco, R; Sammarco, G, 2015) |
| "paclitaxel against gastric cancer with peritoneal dissemination by inhibiting NF-κB activation in mice." | 1.39 | Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice. ( Fujiwara, Y; Furukawa, K; Haruki, K; Iwase, R; Misawa, T; Ohashi, T; Shiba, H; Uwagawa, T; Yanaga, K, 2013) |
| "On the first postoperative day, acute pulmonary thromboembolism (PTE) with occlusion of the pulmonary trunk occurred, and the cardiovascular state became unstable." | 1.33 | [Postoperative acute pulmonary thromboembolism treated with nafamostat mesilate]. ( Nuriya, E; Tsuda, K; Yamada, K; Yamamoto, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leporini, C | 1 |
| Ammendola, M | 1 |
| Marech, I | 1 |
| Sammarco, G | 1 |
| Sacco, R | 1 |
| Gadaleta, CD | 1 |
| Oakley, C | 1 |
| Russo, E | 1 |
| De Sarro, G | 1 |
| Ranieri, G | 1 |
| Haruki, K | 1 |
| Shiba, H | 1 |
| Fujiwara, Y | 1 |
| Furukawa, K | 1 |
| Iwase, R | 1 |
| Uwagawa, T | 1 |
| Misawa, T | 1 |
| Ohashi, T | 1 |
| Yanaga, K | 1 |
| Tsuda, K | 1 |
| Yamada, K | 1 |
| Yamamoto, K | 1 |
| Nuriya, E | 1 |
1 review available for nafamostat and Stomach Neoplasms
| Article | Year |
|---|---|
Targeting mast cells in gastric cancer with special reference to bone metastases.
Topics: Animals; Antigens, CD34; Benzamides; Benzamidines; Bone and Bones; Bone Neoplasms; Bone Resorption; | 2015 |
2 other studies available for nafamostat and Stomach Neoplasms
| Article | Year |
|---|---|
Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice.
Topics: Animals; Antineoplastic Agents; Benzamidines; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Ce | 2013 |
[Postoperative acute pulmonary thromboembolism treated with nafamostat mesilate].
Topics: Aged; Anticoagulants; Benzamidines; Female; Gastrectomy; Guanidines; Humans; Postoperative Complicat | 2006 |